Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. - Wikidata - wikimedia - TriplyDB

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

http://www.wikidata.org/entity/Q35029475

about

Interaction of tumor cells with the microenvironment Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?The network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancer Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis Links between cancer stem cells and epithelial-mesenchymal transition Py2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivo Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Hypoxia-inducible factor 1 and breast cancer metastasis n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1 Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow.Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling.Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence GD2 expression in breast cancer.BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition Endothelial induced EMT in breast epithelial cells with stem cell properties Circulating tumor cells in breast cancer.Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition Micro-RNA-632 downregulates DNAJB6 in breast cancer.MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.Metaplastic carcinoma of the breast: an immunohistochemical study Towards elucidating the connection between epithelial-mesenchymal transitions and stemness At the dawn of a new discovery: the potential of breast milk stem cells.NanoFlares for the detection, isolation, and culture of live tumor cells from human blood.Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.MicroRNA-mediated drug resistance in breast cancer.Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectives Molecular characterization and targeted therapeutic approaches in breast cancer Extracellular NM23 Signaling in Breast Cancer: Incommodus Verum.Cell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.

P2860

Q21245506-07284E1F-B272-49F3-A783-561C830E82D7 Q26771988-2999E683-7830-495B-B337-C8CA03D4538D Q26785448-F27FCFB7-9528-433A-B1E0-D5E3F0A88BEB Q26799987-35B2EBE0-8D49-4187-941B-04FFCDD20278 Q26827815-41B55E5C-248E-4C3E-8B92-7D7C9EADC7CD Q26851620-8B931AFA-776C-44CC-80F6-F9C1FB4B843A Q26864979-8EFEDF7D-489D-455E-88F0-70AE5FC47F7A Q26991480-236694D9-6386-46DF-AA30-6AF3E6512915 Q27004529-73122444-5CEC-4181-BD05-60C28426F7B8 Q27340972-77345786-488F-4E31-A5D8-0816CB6202E5 Q28067549-ACC17ED8-7979-4C54-8FCD-BDB373BE080B Q28087393-16D3B571-13D0-439F-BA9F-6DFBC0388CA5 Q28482126-DFC4F45A-20BB-4417-9C60-A4289283CFB4 Q28818141-211A4208-9626-44F2-AB29-E7A4592CBC89 Q30662016-B2294C01-2BF6-47F3-BE36-FE857C453392 Q33607505-1BCE49EA-A2DA-4F7B-960E-A73EFA1428A0 Q33756426-17EA801D-E834-4EC3-ADC3-358737187B44 Q33759991-73277168-154A-4A76-9BED-C37D375E9B57 Q33761830-B23BE6DA-360E-4CF8-AA1C-EC251F87ED67 Q33798713-1049B961-97F6-4557-B5C9-92FE1BAA9CDA Q33909576-CA81D9A0-41A2-4258-8832-8EBFFF374463 Q34018866-49D7CB25-85DF-40A8-B4C6-96B7B20D9503 Q34077349-7C40A9D9-8BA6-4165-86F4-F2B7067EBED5 Q34271512-F21CDD4B-C859-417C-8C41-506C5E209144 Q34282577-4FF2799A-8292-4FEE-ABF2-0BFC7A5BFD27 Q34302220-24D7B225-812A-4D43-AF70-77037A53C516 Q34326206-8932AFD2-7F75-49D8-A54D-BB7578208B51 Q34391559-29BF371F-492E-4856-9F0E-5C7DE19EBAE6 Q34404867-93907FED-DB9F-49AE-80C0-A879036361E4 Q34468034-CD703E84-E074-4BAC-B336-B72315D391DA Q34470537-FC0CDA13-BE8D-44B6-A46A-268300A6ECD5 Q34471916-B73697E7-95CE-4B3D-A239-DC1BFB74F65F Q34661397-2DD6D430-9F70-41F9-8836-D98F476B3109 Q35000231-B301B509-1B0E-4226-933C-A1E56EF2CE54 Q35106947-4975E3C2-B8AB-41F2-84C0-38032DFF9D24 Q35165126-8EA8CEB3-BD5A-4D4D-8469-F6DFAF6CB955 Q35485571-639EFB84-6A96-452B-93FE-10D28BC92D66 Q35530143-D7A059D1-B3BB-4630-A662-9A27B2009B29 Q35546643-DE2BFE99-EA9C-4D17-9240-68F02F8A93D5 Q35598363-5D5DD874-4280-4125-B4FA-560B4DE08A14

P2860

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

http://www.wikidata.org/entity/Q35029475

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Epithelial-mesenchymal transit ...... in breast cancer progression.

@ast

Epithelial-mesenchymal transit ...... in breast cancer progression.

@en

type

label

Epithelial-mesenchymal transit ...... in breast cancer progression.

@ast

Epithelial-mesenchymal transit ...... in breast cancer progression.

@en

prefLabel

Epithelial-mesenchymal transit ...... in breast cancer progression.

@ast

Epithelial-mesenchymal transit ...... in breast cancer progression.

@en

P1433

Q35029475-DEC9823A-F753-4D79-8240-1B0E8EBD24DC

P1476

Q35029475-4F4276E4-CD9E-455D-90D4-115666479DE2

P2093

Q35029475-0C38EA64-6FC0-4D3B-83DF-F223A0734B1C

Q35029475-60249703-8D79-42C3-8246-F63FF7A9AF12

Q35029475-7B330979-7031-4654-939C-B2EF30400C1F

Q35029475-B6181E29-6F8A-47B3-B210-D6784F4568EB

Q35029475-B77ABFAD-B58C-4196-9665-08EA0F7D33C1

Q35029475-E5328E82-85B8-42CC-95B4-140CEFFDAA86

P2860

Q35029475-00C41834-1676-4CF0-8C10-9FDBF6BE881F

Q35029475-020ED103-2A80-45A7-982C-36AEFC69716F

Q35029475-03DFCC11-ACD0-4E6A-8B3A-94F09EBF0187

Q35029475-04D869A9-6081-4416-A476-B7BEE3603EE7

Q35029475-06D9E134-4EBC-4F83-B3FC-28F6E1FDE030

Q35029475-07DB4332-79BF-4FF3-BFE1-CD5D83974C3B

Q35029475-0A4B1894-4379-4A31-9B53-D079C889321B

Q35029475-0C730BFF-55E2-4F81-8524-F6E385311D86

Q35029475-0E1C26E3-A49D-4FF0-BB48-D5225112A69C

Q35029475-0F174A7A-4B0F-4FA1-B210-896BA0BC6D75

P2888

Q35029475-83F3527A-48AF-4D33-8E73-B3C086F29CEA

P304

Q35029475-EA58B890-73E6-4CCE-8019-A9875ED72A3D

P31

Q35029475-7829ABA5-9FEB-4C35-BF77-36A498239522

Q35029475-AD241122-11AF-4520-BFCF-125FFBFAFE37

P356

Q35029475-B3A1B8BC-EEF9-4E6F-84EE-40C2DFFD8B2B

P433

Q35029475-814D7E79-B929-41F5-B139-B9F37B585D5E

P478

Q35029475-249EDA2B-3B44-4E93-8129-DFB02E8D7A55

P577

Q35029475-3DFECA3C-5020-4FAD-9728-2B8E894AA136

P5875

Q35029475-72B8BC3E-1112-4290-9CAA-5A712CBD927E

P6179

Q35029475-EAC161EF-FA7C-41E0-9EE2-82D6CA721338

P698

Q35029475-D0F477F1-49E6-47DF-8F8F-6AAD22A13740

P921

Q35029475-562A51A6-9A43-4C97-A5DC-6C6BF4C2D276

Q35029475-574E4820-39E4-4AFC-BA61-961E2D06875F

Q35029475-C000889F-0B9B-4491-90C3-FC78DD9F374D

P932

Q35029475-D0FF2484-B840-4F56-AA33-DE749CF35D49

P356

P1433

Breast Cancer Research

P1476

Epithelial-mesenchymal transit ...... in breast cancer progression.

@en

P2093

Caitlin D May

http://www.w3.org/2001/XMLSchema#string

Kurt W Evans

http://www.w3.org/2001/XMLSchema#string

Nathalie Sphyris

http://www.w3.org/2001/XMLSchema#string

Sendurai A Mani

http://www.w3.org/2001/XMLSchema#string

Steven J Werden

http://www.w3.org/2001/XMLSchema#string

Wenjun Guo

http://www.w3.org/2001/XMLSchema#string

P2860

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

P2888

P304

202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2789

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50362787

http://www.w3.org/2001/XMLSchema#string

P6179

1013292301

http://www.w3.org/2001/XMLSchema#string

P698

21392411

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

P932

3109556

http://www.w3.org/2001/XMLSchema#string